Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiyao Sheng

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Scientific Reports|May 9, 2025
Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccessZeyu Wang, Jiyao Sheng, Xuewen Zhang
Frontiers in Human Neuroscience|November 23, 2017
Recent Advances in Non-invasive Brain Stimulation for Major Depressive DisorderShui Liu, Jiyao Sheng, Bingjin Li, et al.
Peerj|June 12, 2020
Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancerXin Wen, Shui Liu, Jiyao Sheng, et al.
Aging|May 24, 2024
Targeting tumor-associated macrophages to reverse antitumor drug resistanceSheng Li, Jiyao Sheng, Dan Zhang, et al.
Frontiers in Medicine|November 29, 2023
Editorial: Advances in chemotherapy-resistant hepatocellular carcinomaShui Liu, Qiao Li, Yongzhi Li, et al.
International Journal of Nanomedicine|November 27, 2025
Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer TherapyShuang-Yin Lei, Hanjiao Qin, Shui Liu, et al.
Pathology Oncology Research : POR|July 29, 2021
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic CancerShui Liu, Yan Cai, E Changyong, et al.
DNA and Cell Biology|February 10, 2022
Rap_GAP Domain of <i>TSC2</i> Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular CarcinomaMengying Cui, Weibo Jiang, Jiyao Sheng, et al.
Frontiers in Immunology|August 18, 2025
Adoptive cell therapy for cancer: combination strategies and biomarkersShiyu Liu, Weibo Jiang, Jiyao Sheng, et al.
Frontiers in Immunology|January 5, 2026
New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosisYufan Liu, Kexin Cong, Qiao Li, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|May 9, 2025
Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccessZeyu Wang, Jiyao Sheng, Xuewen Zhang
Frontiers in Human Neuroscience|November 23, 2017
Recent Advances in Non-invasive Brain Stimulation for Major Depressive DisorderShui Liu, Jiyao Sheng, Bingjin Li, et al.
Peerj|June 12, 2020
Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancerXin Wen, Shui Liu, Jiyao Sheng, et al.
Aging|May 24, 2024
Targeting tumor-associated macrophages to reverse antitumor drug resistanceSheng Li, Jiyao Sheng, Dan Zhang, et al.
Frontiers in Medicine|November 29, 2023
Editorial: Advances in chemotherapy-resistant hepatocellular carcinomaShui Liu, Qiao Li, Yongzhi Li, et al.
International Journal of Nanomedicine|November 27, 2025
Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer TherapyShuang-Yin Lei, Hanjiao Qin, Shui Liu, et al.
Pathology Oncology Research : POR|July 29, 2021
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic CancerShui Liu, Yan Cai, E Changyong, et al.
DNA and Cell Biology|February 10, 2022
Rap_GAP Domain of <i>TSC2</i> Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular CarcinomaMengying Cui, Weibo Jiang, Jiyao Sheng, et al.
Frontiers in Immunology|August 18, 2025
Adoptive cell therapy for cancer: combination strategies and biomarkersShiyu Liu, Weibo Jiang, Jiyao Sheng, et al.
Frontiers in Immunology|January 5, 2026
New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosisYufan Liu, Kexin Cong, Qiao Li, et al.
Pageof 5